Detection and significance of fluconazole resistance in oropharyngeal candidiasis in human immunodeficiency virus-infected patients

Journal of Infectious Diseases

Volumn 174, Issue 4, 1996, Pages 821-827

  Revankar, Sanjay G ^a   Kirkpatrick, William R ^a   McAtee, Robert K ^a   Dib, Olga P ^a   Fothergill, Annette W ^a   Redding, Spencer W ^a   Rinaldi, Michael G ^a   Patterson, Thomas F ^a  

^a UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

FLUCONAZOLE;

ADULT; ARTICLE; CANDIDA ALBICANS; CANDIDIASIS; CLINICAL ARTICLE; CLINICAL TRIAL; DRUG EFFICACY; DRUG RESISTANCE; FEMALE; HUMAN; HUMAN IMMUNODEFICIENCY VIRUS INFECTION; MALE; MINIMUM INHIBITORY CONCENTRATION; OROPHARYNX; PRIORITY JOURNAL; YEAST;

EID: 0029792490     PISSN: 00221899     EISSN: None     Source Type: Journal    
DOI: 10.1093/infdis/174.4.821     Document Type: Article

References (31)

1. Klein RS, Harris CA, Small CB, Moll B, Lesser M, Friedland GH. Oral candidiasis in high-risk patients as the initial manifestation of the acquired immunodeficiency syndrome. N Engl J Med 1984;311:354-8.
2. McCarthy GM, Mackie ID, Koval J, Sandhu HS, Daley TD. Factors associated with increased frequency of HIV-related oral candidiasis. J Oral Pathol Med 1991;20:332-6.
3. Nielsen H, Bentsen KD, Hojtved L, et al. Oral candidiasis and immune status of HIV-infected patients. J Oral Pathol Med 1994;23:140-3.
4. Plettenberg A, Reisinger E, Lenzner U, et al. Oral candidosis in HIV-infected patients. Prognostic value and correlation with immunological parameters. Mycoses 1990;33:421-5.
5. Rabeneck L, Crane MM, Risser JMH, Lacke CE, Wray NP. A simple clinical staging system that predicts progression to AIDS using CD4 count, oral thrush, and night sweats. J Gen Intern Med 1993;8:5-9.
6. De Wit S, Weerts D, Goossens H, Clumeck N. Comparison of fluconazole and ketoconazole for oropharyngeal candidiasis in AIDS. Lancet 1989;1:746-7.
7. De Wit S, Urbain D, Rahir F, Weerts D, Clumeck N. Efficacy of oral fluconazole in the treatment of AIDS associated oesophageal candidiasis. Eur J Clin Microbiol Infect Dis 1991;10:503-5.
8. Lopez-Dupla M, Sanz PM, Garcia VP, et al. Clinical, endoscopie, immunologic, and therapeutic aspects of oropharyngeal candidiasis in HIV-infected patients: a survey of 114 cases. Am J Gastroenterol 1992;87:1771-6.
9. Koletar SL, Russell JA, Fass RJ, Plouffe JF. Comparison of oral fluconazole and clotrimazole troches as treatment for oral candidiasis in patients infected with human immunodeficiency virus. Antimicrob Agents Chemother 1990;34:2267-8.
10. Horn CA, Washbum RG, Givner LB, Peacock JE Jr, Pegram PS. Azole resistant oropharyngeal and esophageal candidiasis in patients with AIDS. AIDS 1995;9:533-5.
11. Just-Nubling G, Gentschew G, Meibner K, et al. Fluconazole prophylaxis of recurrent oral candidiasis in HIV-positive patients. Eur J Clin Microbiol Infect Dis 1991;10:917-21.
12. Sanguineti A, Cannichael JK, Campbell K. Fluconazole-resistant Candida albicans after long-term suppressive therapy. Arch Intern Med 1993;153:1122-4.
13. Rex JH, Pfaller MA, Barry AL, et al. Antifungal susceptibility testing of isolates from a randomized, multicenter trial of fluconazole versus amphotericin B as treatment of nonneutropenic patients with candidemia. Antimicrob Agents Chemother 1995;39:40-4.
14. Fan-Havard P, Capano D, Smith SM, Mangia A, Eng RH. Development of resistance in Candida isolates from patients receiving prolonged antifungal therapy. Antimicrob Agents Chemother 1991;35:2302-5.
15. Johnson EM, Warnock DW, Luker J, Porter SR, Scully C. Emergence of azole drug resistance in Candida species from HIV-infected patients receiving prolonged fluconazole therapy for oral candidiasis. J Antimicrob Chemother 1995;35:103-14.
16. Powderly WG. Resistant candidiasis. AIDS Res Hum Retroviruses 1994;10:925-9.
17. Law D, Moore CB, Wardle HM, Ganguli LA, Keaney MGL, Denning DW. High prevalence of antifungal resistance in Candida spp. from patients with AIDS. J Antimicrob Chemother 1994;34:659-68.
18. Powderly WG, Robinson K, Keath EJ. Molecular epidemiology of recurrent oral candidiasis in human immunodeficiency virus-positive patients: evidence for two patterns of recurrence. J Infect Dis 1993;168:463-6.
19. Redding S, Smith J, Farinacci G, et al. Resistance of Candida albicans to fluconazole during treatment of oropharyngeal candidiasis in a patient with AIDS: documentation by in vitro susceptibility testing and DNA subtype analysis. Clin Infect Dis 1994;18:240-2.
20. Ruhnke M, Eigler A, Tennagen I, Geiseler B, Engelmann E, Trautmann M. Emergence of fluconazole-resistant strains of Candida albicans in patients with recurrent oropharyngeal candidosis and human immunodeficiency virus infection. J Clin Microbiol 1994;32:2092-8.
21. Sangeorzan JA, Bradley SF, He X, et al. Epidemiology of oral candidiasis in HIV-infected patients: colonization, infection, treatment, and emergence of fluconazole resistance. Am J Med 1994;97:339-46.
22. White A, Goetz MB. Azole-resistant Candida albicans: report of two cases of resistance to fluconazole and review. Clin Infect Dis 1994;19:687-92.
23. Maenza JR, Keruly JC, Moore RD, Chaisson RE, Merz WG, Gallant JE. Risk factors for fluconazole-resistant candidiasis in human immunodeficiency virus-infected patients. J Infect Dis 1996;173:219-25.
24. Pfaller MA, Rhine-Chalberg J, Redding SW, et al. Variations in fluconazole susceptibility and electrophoretic karyotype among oral isolates of Candida albicans from patients with AIDS and oral candidiasis. J Clin Microbiol 1994;32:59-64.
25. Revankar SG, Kirkpatrick WR, Dib O, et al. Detection of fluconazole resistant yeasts with chromogenic agar [abstract D38]. In: Program and abstracts of the 35th Interscience Conference on Antimicrobial Agents and Chemotherapy (San Francisco). Washington, DC: American Society for Microbiology, 1995.
26. Patterson TF, Revankar SG, Kirkpatrick WR, et al. Simple method for detecting fluconazole resistant yeasts with chromogenic agar. J Clin Microbiol 1996;34:1794-7.
27. National Committee for Clinical Laboratory Standards. Reference method for broth dilution antifungal susceptibility testing of yeasts: proposed standard. Villanova, PA: NCCLS, 1992; document M27-P.
28. Millon L, Manteaux A, Reboux G, et al. Fluconazole-resistant recurrent oral candidiasis in human immunodeficiency virus-positive patients: persistence of Candida albicans strains with the same genotype. J Clin Microbiol 1994;32:1115-8.
29. Stevens DA, Greene SI, Lang OS. Thrush can be prevented in patients with acquired immunodeficiency syndrome and the acquired immunodeficiency syndrome-related complex. Arch Intern Med 1991;151:2458-64.
30. Thoma-Greber E, Korting HC, Bogner J, Goebel FD. Fluconazole-resistant oral candidosis in a repeatedly treated female AIDS patient. Mycoses 1994;37:35-8.
31. Heald A, Cox G, Schell W, Bartlett J, Miralles D, Perfect J. Oropharyngeal yeast flora in human immunodeficiency virus (HIV) infected patients receiving long-term continuous fluconazole therapy [abstract 1227]. In: Program and abstracts of the 34th Interscience Conference on Antimicrobial Agents and Chemotherapy (Orlando, FL). Washington, DC: American Society for Microbiology, 1994.